Clinical Trial Update: Changyanning Tablet for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update for Changyanning Tablet evaluating its use in diarrhea-predominant irritable bowel syndrome across Phase 2 and Phase 3, with status curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diarrhea-predominant Irritable Bowel Syndrome

Drugs mentioned

• Changyanning Tablet

Snippet

Sponsor: Mei Han | Conditions: Diarrhea-Predominant Irritable Bowel Syndrome | Phase 2, Phase 3 | Status: UNKNOWN